MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$17,606
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Sales
0 55* NaN 0
Service revenue
0 0* 0 0
Cost of revenues
0 43* NaN 0
Gross profit
0 12 0 0
General and administrative
31,335 22,907 25,795 28,200
Total operating expenses
31,335 22,907 25,795 28,200
Operation income
-31,335 -22,895 -25,795 -28,200
Other income
15,829 NaN NaN NaN
Interest expense
2,100 2,100 2,100 2,100
Loss from inventory impairment
0 174,745 NaN NaN
Income tax provision
0 0 0 0
Net loss
-17,606 -199,740 -27,895 -30,300
Diluted EPS
0 -0.002 NaN NaN
Diluted Average Shares
99,000,000 104,133,334 96,433,333 96,433,333
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net loss-$17,606 (54.31%↑ Y/Y)Other income$15,829 Operation income-$31,335 (14.00%↑ Y/Y)Interest expense$2,100 (0.00%↑ Y/Y)Total operatingexpenses$31,335 (-14.00%↓ Y/Y)General andadministrative$31,335 (-14.00%↓ Y/Y)

GOLDENWELL BIOTECH, INC. (GWLL)

GOLDENWELL BIOTECH, INC. (GWLL)